SummaryRMgm-168
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption, Introduction of a transgene |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 16430692 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | T. Ishino; M. Yuda |
Name Group/Department | Department of Medical Zoology |
Name Institute | Mie University School of Medicine |
City | Mie |
Country | Japan |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-168 |
Principal name | cdpk3(-)/gfp |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Normal numbers of ookinetes are produced. These ookinetes have a (light microscope) morphology that is comparable to wild type ookinetes. Ookinetes show a strong reduction (99%) in the formation of oocysts in A. stephensi mosquitoes. Ookinetes fail to invade midgut epithelial cells. Ookinetes are severely impaired in the ability to migrate in vitro through a gel structure (Matrigel; see 'Additional information'). Ookinetes were able to move on the gel surface. |
Oocyst | Ookinetes show a strong reduction (99%) in the formation of oocysts in A. stephensi mosquitoes. The few oocysts that are produced, form normal numbers of sporozoites that are infectious to the mammalian host as determined by intravenous inoculation of sporozoites in rats. |
Sporozoite | Not different from wild type |
Liver stage | Not different from wild type |
Additional remarks phenotype | Mutant/mutation Additional information An independent mutant lacking expression of CDPK3, RMgm-154, has been generated which show a comparable defect in ookinete to oocyst transition. However, instead of the specific defect in traversal of the layer covering the epithelial cells, a more general defect in motility of the ookinetes was observed, suggesting a role for CDPK3 in regulating productive gliding motility of ookinetes. Disruption of the P. falciparum ortholog has been attempted (Solyakov et al., 2011, Nat Commun, 2:565). |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0408200 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0310100 | ||||||||||||||||||||||||
Gene product | calcium-dependent protein kinase 3 | ||||||||||||||||||||||||
Gene product: Alternative name | CDPK3 | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | Plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | pbdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | This mutant has been generated by a genetic cross between mutant RMgm-165 lacking expression of CDPK3 and mutant RMgm-166 that expresses GFP. Mosquitoes were fed on a mouse infected with RMgm-166 parasites and RMgm-165 parasites in the ratio of 1:9. Mosquitoes were fed on this mouse, and sporozoites were collected from mosquito salivary glands and injected into a rat intravenously. When parasitaemia reached 1%, erythrocytes infected by GFP-expressing parasites were sorted by an Epics Altra (Beckman Coulter, Fullerton, CA), and injected into a fresh rat. Finally, cdpk3(-)-GFP-expressing parasites were separated by limiting dilution. | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |
top of page | |||||||||||||||||||
Type and details of transgene | |||||||||||||||||||
Is the transgene Plasmodium derived | Transgene: not Plasmodium | ||||||||||||||||||
Transgene name | GFP | ||||||||||||||||||
top of page | |||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||
Inducable system used | No | ||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||
Type of plasmid/construct | Plasmid double cross-over | ||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||
Selectable marker used to select the mutant parasite | pbdhfr | ||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||
Additional remarks genetic modification | This mutant has been generated by a genetic cross between mutant RMgm-165 lacking expression of CDPK3 and mutant RMgm-166 that expresses GFP. Mosquitoes were fed on a mouse infected with RMgm-166 parasites and RMgm-165 parasites in the ratio of 1:9. Mosquitoes were fed on this mouse, and sporozoites were collected from mosquito salivary glands and injected into a rat intravenously. When parasitaemia reached 1%, erythrocytes infected by GFP-expressing parasites were sorted by an Epics Altra (Beckman Coulter, Fullerton, CA), and injected into a fresh rat. Finally, cdpk3(-)-GFP-expressing parasites were separated by limiting dilution. | ||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||
top of page | |||||||||||||||||||
Other details transgene | |||||||||||||||||||
top of page | |||||||||||||||||||
Promoter | |||||||||||||||||||
Gene Model of Parasite | PBANKA_0711900 | ||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0818900 | ||||||||||||||||||
Gene product | heat shock protein 70 | ||||||||||||||||||
Gene product: Alternative name | HSP70 | ||||||||||||||||||
| |||||||||||||||||||
top of page | |||||||||||||||||||
3'-UTR | |||||||||||||||||||
Gene Model of Parasite | PBANKA_0711900 | ||||||||||||||||||
Gene product | heat shock protein 70 | ||||||||||||||||||
Gene product: Alternative name | HSP70 | ||||||||||||||||||
| |||||||||||||||||||
Insertion/Replacement locus | |||||||||||||||||||
Replacement / Insertion | Insertion locus | ||||||||||||||||||
Gene Model of Parasite | PBANKA_0719300 | ||||||||||||||||||
Gene product | bifunctional dihydrofolate reductase-thymidylate synthase, putative | ||||||||||||||||||
Gene product: Alternative name | dhfr/ts | ||||||||||||||||||
| |||||||||||||||||||
top of page |